PGFC
DGX icon

Peapack-Gladstone Financial Corp’s Quest Diagnostics DGX Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Sell
10,620
-325
-3% -$63.8K 0.03% 338
2026
Q1 		$2.15M Sell
10,945
-70
-0.6% -$13.6K 0.03% 329
2025
Q4 		$1.91M Sell
11,015
-97
-0.9% -$17.7K 0.02% 342
2025
Q3 		$2.12M Sell
11,112
-32
-0.3% -$5.68K 0.03% 335
2025
Q2 		$2M Buy
11,144
+9
+0.1% +$1.56K 0.03% 331
2025
Q1 		$1.89M Buy
11,135
+1,410
+14% +$232K 0.03% 334
2024
Q4 		$1.47M Hold
9,725
– – 0.02% 355
2024
Q3 		$1.51M Hold
9,725
– – 0.02% 358
2024
Q2 		$1.33M Hold
9,725
– – 0.02% 365
2024
Q1 		$1.29M Sell
9,725
-202
-2% -$26.2K 0.02% 372
2023
Q4 		$1.37M Sell
9,927
-248
-2% -$32.6K 0.02% 362
2023
Q3 		$1.24M Sell
10,175
-15
-0.1% -$2K 0.02% 359
2023
Q2 		$1.43M Buy
10,190
+29
+0.3% +$4K 0.03% 341
2023
Q1 		$1.44M Sell
10,161
-200
-2% -$28.6K 0.03% 335
2022
Q4 		$1.62M Sell
10,361
-13
-0.1% -$1.87K 0.03% 320
2022
Q3 		$1.27M Sell
10,374
-219
-2% -$28.8K 0.03% 340
2022
Q2 		$1.41M Buy
10,593
+17
+0.2% +$2.32K 0.03% 315
2022
Q1 		$1.45M Buy
10,576
+10
+0.1% +$1.39K 0.03% 328
2021
Q4 		$1.83M Sell
10,566
-46
-0.4% -$7K 0.03% 297
2021
Q3 		$1.54M Buy
10,612
+250
+2% +$36.6K 0.03% 311
2021
Q2 		$1.37M Buy
10,362
+5
+0% +$655 0.03% 292
2021
Q1 		$1.33M Buy
10,357
+1,627
+19% +$200K 0.03% 285
2020
Q4 		$1.04M Hold
8,730
– – 0.03% 255
2020
Q3 		$999K Hold
8,730
– – 0.04% 226
2020
Q2 		$995K Hold
8,730
– – 0.04% 224
2020
Q1 		$701K Sell
8,730
-241
-3% -$24.9K 0.03% 237
2019
Q4 		$958K Sell
8,971
-122
-1% -$12.7K 0.04% 202
2019
Q3 		$974K Buy
9,093
+92
+1% +$9.45K 0.04% 199
2019
Q2 		$916K Buy
9,001
+26
+0.3% +$2.5K 0.04% 202
2019
Q1 		$807K Buy
8,975
+163
+2% +$14.1K 0.04% 204
2018
Q4 		$734K Buy
8,812
+150
+2% +$14.1K 0.04% 202
2018
Q3 		$934K Buy
8,662
+4,141
+92% +$454K 0.05% 193
2018
Q2 		$497K Buy
4,521
+300
+7% +$31.3K 0.03% 231
2018
Q1 		$423K Sell
4,221
-108
-2% -$11.1K 0.02% 246
2017
Q4 		$426K Hold
4,329
– – 0.02% 248
2017
Q3 		$405K Hold
4,329
– – 0.02% 252
2017
Q2 		$481K Hold
4,329
– – 0.03% 226
2017
Q1 		$425K Sell
4,329
-400
-8% -$38.1K 0.03% 240
2016
Q4 		$435K Buy
4,729
+1
+0% +$86 0.03% 220
2016
Q3 		$400K Hold
4,728
– – 0.03% 227
2016
Q2 		$385K Hold
4,728
– – 0.03% 229
2016
Q1 		$338K Hold
4,728
– – 0.02% 247
2015
Q4 		$336K Buy
4,728
+300
+7% +$20.2K 0.02% 252
2015
Q3 		$272K Buy
4,428
+200
+5% +$14K 0.02% 274
2015
Q2 		$307K Buy
4,228
+148
+4% +$10.9K 0.02% 267
2015
Q1 		$314K Hold
4,080
– – 0.02% 273
2014
Q4 		$274K Hold
4,080
– – 0.02% 269
2014
Q3 		$248K Sell
4,080
-400
-9% -$24.6K 0.02% 268
2014
Q2 		$263K Sell
4,480
-80
-2% -$4.68K 0.02% 267
2014
Q1 		$264K Sell
4,560
-620
-12% -$33.2K 0.02% 262
2013
Q4 		$277K Sell
5,180
-2,860
-36% -$170K 0.02% 250
2013
Q3 		$497K Sell
8,040
-4,475
-36% -$268K 0.04% 193
2013
Q2 		$759K Buy
+12,515
New +$746K 0.07% 156

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Peapack-Gladstone Financial Corp's DGX Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp reduced its Quest Diagnostics (DGX) stake by 3% in Q2 2026, selling an estimated $63.8K and leaving 10,620 shares worth $2.25M. The position accounts for 0.03% of the portfolio, ranked #338.

Peapack-Gladstone Financial Corp first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 10,620 shares of Quest Diagnostics worth $2.25M as of Q2 2026.
  • Peapack-Gladstone Financial Corp sold 325 Quest Diagnostics shares in Q2 2026, an estimated $63.8K.
  • Quest Diagnostics made up 0.03% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #338 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.